Corbus Pharmaceuticals Holdings, Inc. Made Headway
Tue, Jan 30, 2024 at 07:19 PM
Corbus Pharmaceuticals Holdings, Inc. (CRBP:NASDAQ) shot up at $25.16, representing a gain of 35.1%. The stock got featured on our News Catalysts scanner on Mon, Jan 29, 2024 at 09:32 AM in the 'INVESTOR UPDATE' category. From Tue, Jan 16, 2024, the stock recorded 80.00% Up Days and 72.73% Green Days
The stock spiked on Fri, Jan 26, 2024 at $39.96 with a volume of 33M+.
About Corbus Pharmaceuticals Holdings, Inc. (CRBP:NASDAQ)
Corbus Pharmaceuticals Holdings Inc is a biopharmaceutical company. Its business involves the development of therapeutics to address serious inflammatory diseases such as cystic fibrosis, systemic sclerosis and skin-predominant dermatomyositis.
Top 10 Gainers:
- Remark Holdings, Inc. (MARK:NASDAQ), 264.43%
- SRAX, Inc. (SRAX:NASDAQ), 99.02%
- NexImmune Inc. (NEXI:NASDAQ), 58.39%
- China Xiangtai Food Co. Ltd. (BTOG:NASDAQ), 48.28%
- SMX (Security Matters) Public Limited Company (SMX:NASDAQ), 47.14%
- Corbus Pharmaceuticals Holdings, Inc. (CRBP:NASDAQ), 35.12%
- Selina Hospitality PLC (SLNA:NASDAQ), 31.23%
- Agrify Corporation (AGFY:NASDAQ), 30.2%
- The Arena Group Holdings Inc. (AREN:NYSEMKT), 29.06%
- Vinco Ventures Inc. (BBIG:NASDAQ), 29.03%